Endlyz Therapeutics emerges with pipeline for Parkinson’s disease - PharmaTimes Research targets lysosomal function restoration for neurodegeneration

#EndlyzTherapeutics #Parkinsonsdisease #neurology #ParkinsonsResearch #lysosomalfunctionrestoration #neurodegeneration #MichaelJFoxFoundationforParkinsonsResearch #ATP13A2 #ATP10B #PARK9gene #QuantumAI #DementiaDiscoveryFund #OxfordScienceEnterprises #ParkinsonsUK
pharmatimes.com/news/endlyz-...